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Background: The first instances of HIV-antibody detection in donated blood in
Pakistan were reported in 1988. Since then, documentation of HIV in blood donors
and of rates of transmission via transfusion has been limited. Previously assumed
to have a low prevalence, HIV is an increasing health concern in Pakistan. Since
there is no national, centralized blood-banking system, there are no reliable data
on which to base estimated risks of transfusion-associated HIV infection. This
study was therefore conducted to estimate the prevalence of HIV in blood donors
and recipients in Pakistan between 1988 and 2012.
Methods: Meta-analyses were undertaken of reported prevalences of HIV in
blood donors and recipients published during 1988–2012. Papers were identified
by searching PubMed, Google, CINAHL and PakMediNet and the websites of the
World Health Organization, the national HIV/AIDS Surveillance Project and the
National AIDS Control Programme of Pakistan. In addition, the 1998–2012 records
of the Aga Khan University blood bank were analysed.
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Results: The 254 abstracts identified at the preliminary search were reviewed and,
after removal of duplications, case-reports, editorials and reviews, 32 papers were
selected that met the inclusion criteria. All studies that reported on HIV antibodies
in blood donors/recipients were included, irrespective of the methodology used.
Since seroconversion had only been confirmed through supplemental testing in a
few papers, the results were analysed separately for reports based on screening
only and confirmed cases. A total of 142 of 2 023 379 blood donors and 4 of
3632 blood recipients were HIV positive, giving an overall pooled seroprevalence
of 0.00111% in blood donors and 0.00325% in blood recipients. The annual
prevalences of HIV in donors at the Aga Khan University blood banks were similar,
ranging from 0.013% to 0.116%.
Conclusion: Very few reports on HIV in blood donors in Pakistan could be
retrieved, and the overall pooled prevalence is low. However, the limited data and
confounding factors mean that that these results may significantly underestimate
the true situation. It is recommended that a complete survey of blood banks should
be conducted throughout the country, in order to provide a more reliable estimate
of the risk of transfusion-associated HIV infection in Pakistan.
Key words: blood bank, blood donors, blood transfusion, HIV, Pakistan,
transfusion-transmitted infection

BACKGROUND
Situated in South Asia, Pakistan is home to 180 million people,
with a 54.7% literacy rate and 61.7% of its people residing
in rural towns.1 Though there are 1830 blood providers in the
176

public and private sectors and nongovernmental organizations
(NGOs),2 the total number of units of blood collected in the
entire country is not known exactly. According to an update in
2009 from the Pakistan Society of Haematology, approximately
3 million units are collected in various thalassaemia centres.3
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In 2000, Luby et al. estimated that blood collection in Karachi
is done primarily on a transfusion-exchange (75%) or a paid
basis (25%).4 Some of the challenges to the transfusion services
include lack of a national blood policy, inadequate recruitment
and donor selection,5 and the cost of screening kits, coupled
with periodic lack of availability of reagents.6,7
The Government of Pakistan has taken several initiatives to
reform blood-safety systems in the country. In 1986–1987,
the National AIDS Control Programme (NACP) was initiated,
with a focus on HIV diagnosis in hospitalized patients
suspected of being infected with HIV, but later shifted its
scope towards HIV prevention, which included mitigation
against transfusion-transmitted HIV. NACP was financed
by the World Health Organization (WHO) and other donors
initially, until the formation of the Joint United Nations
Programme on HIV/AIDS (UNAIDS) in 1996.8 An important
step was promulgation of the Safe Blood Transfusion Act by
provincial legislature in 1997, under which the Sindh Blood
Transfusion Authority (SBTA) was formed.9 SBTA enrolled
146 banks in the province of Sindh that met its standards, and
closed down 126 substandard blood banks.10 Similar initiatives
were subsequently taken by other provinces. More recently, the
government officially consolidated its blood-safety initiatives,
by establishing a National Blood Transfusion Project (NBTP)
in March 2009. With NBTB established at the national and
provincial levels, the foundation has now been laid for a
system that will ensure adequate and nationwide access to
a safe, adequate and affordable blood supply.11 The German
Federal Ministry for Economic Cooperation and Development
is providing technical and financial support for this initiative.
In a recent meta-analysis, the national prevalence of hepatitis
C and B virus in blood donors in Pakistan was estimated to
be 2.8% and 2.3% respectively.12 However, there is a paucity
of data on the prevalence of HIV in blood donors and rates
of transfusion-transmitted HIV. For example, it is not known
whether the seroprevalence of HIV is static or increasing in
Pakistani blood donors. Initial reports of transfusion-associated
HIV were published in 1988 by Mujeeb and Hashmi13 and
Khanani et al.14 For 2013, the estimated adult prevalence of
HIV in Pakistan was 0.07% and there were an estimated 2200
HIV-related deaths.1 In 2009, UNAIDS Pakistan and NACP
estimated that there were 98 000 (range 79 000–120 000)
HIV cases in Pakistan, with an overall HIV prevalence of
less than 0.05%; and that seroprevalence among injecting
drug users (an estimated prevalence of 20%) and their sexual
contacts, including male and transgender hijra sex workers,
was increasing.8
Since documentation of transfusion transmission of HIV has
been limited, this study aimed to estimate the prevalence of
HIV in blood donors and recipients during 1988–2012, through
meta-analysis of published data. In addition, data from the
Aga Khan University blood bank records for 1998–2012 were
analysed.

Methods
Search strategy
The MOOSE (Meta-analysis Of Observational Studies in
Epidemiology) group checklist for reporting meta-analysis
of observational studies was used.15 Two authors conducted
individual searches for papers published in the past 25
years (from January 1988 to December 2012), using all
databases available to the institute, i.e. PubMed, Google
search, CINAHL and PakMediNet. The latter is a search
engine that encompasses the non-indexed locally published
literature. The following key words were used: “HIV” AND
“blood donors”, “blood recipients”, “multiply transfused”,
“thalassaemia”, “haemophilia” AND “Pakistan”. Additional
articles were identified by searching for specific authors in
this field and through the cited references of relevant articles
from the Google search engine. WHO, the Pakistan HIV/AIDS
Surveillance Project and NACP were also searched, to capture
any additional relevant papers. Bibliographies of published full
manuscripts were searched for additional manuscripts. Only
papers published in English were included, as local medical
journals are published in this language.

Inclusion and exclusion criteria
The preliminary search yielded 254 abstracts, 190 from
PubMed, 21 from CINAHL and 43 from PakMediNet. After
removing duplications, two experts independently selected
38 abstracts that were relevant. Case-reports, editorials and
reviews (n = 6) were excluded from further analysis; 32 papers
met the inclusion criteria for review. All studies that reported
on HIV antibodies in blood donors/recipients were included,
irrespective of the methodology used. Since only a few papers
reported that seroconversion had been confirmed through
supplemental testing, the results were analysed separately for
reports based on screening only and confirmed cases.

Data handling and statistical analysis
Data regarding the time period of the study, region (province),
population of study (donor or recipient), total sample size,
percentages and numbers of positive cases, and methodology
were extracted from the articles. If the same study included
both donors and recipients or had been done in more than one
location, it was split and the results were indicated separately
according to the group. Where results were mentioned in
percentages, the absolute values were calculated from the
population denominator. STATA 12 was used to analyse
the data for the pooled prevalence. All meta-analyses were
evaluated for heterogeneity, using the χ2-based I2 test. I2 values
were interpreted as: 0%, 25%, 50% and 75%, to indicate
no heterogeneity, low-level, moderate-level or high-level
heterogeneity, respectively. For moderate-level or high-level
heterogeneity, a random-effects meta-analysis was performed.
Forest plots for unadjusted prevalence estimates with 95%
confidence limits were generated.16 A P value of <0.05 was
considered significant.
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took part in the study;14 this was a small study with 121 donors,
reporting HIV in one donor.

Aga Khan University blood
bank data, 1998–2012
Blood-bank donor data from the records of the Aga Khan
University were also analysed. Data from all blood donors
enrolled and tested for HIV between 1998 and 2012 were
included. The methodology was enzyme-linked immunosprbent
assay (ELISA; Axysm and ARCHITECT ci1000, Abbott
Diagnostic Division, Abbott Park, IL, United States of
America) until 2009 and chemiluminescence (Vitros©, Ortho
Clinical Diagnostics, Johnson & Johnson, Raritan, NY, United
States of America) in later years. From July 2011, reactive
samples were retested on another instrument (Cobas® 601e
analyser, Roche Diagnostics GmbH, Mannheim, Germany).
Repeatedly reactive samples were further confirmed through
western blot.

Results
The full texts of 32 published papers were eligible for analysis.
Twenty-five manuscripts related to HIV prevalence in blood
donors were found,17–41 six that described HIV risk in both
donors and recipients,13,14,42–45 and only one study that was
dedicated exclusively to HIV seroprevalence in transfusion
recipients.46

HIV seroprevalence and methodology
used in blood donors
Thirty-one studies were evaluated to describe the prevalence
of HIV in blood donors in Pakistan.13,14,17–45 The overall
pooled seroprevalence of HIV in blood donors was 0.00111%
(95% confidence interval [CI] = –0.00044% to 0.00267%),
I2 = 89.7%, P < 0.00001) (see Fig. 1). The data were from
nine large cities of the country and 10 studies were conducted
in the city of Karachi alone,13,14,17–20,38,40, 42,45 while six and four
were conducted in Lahore25,28,30,36,37,44 and Peshawar,22,39,41,43
respectively. ELISA was the predominant screening
technology used in 27 studies;13,14,17–20,22,23,25,29,32–41,42,45 one
paper did not describe the methodology used,31 while the
remaining three studies were based exclusively either on
immunochromatographic testing24,30 or latex agglutination.21
During 1988–2012, a total of 142 donors were reported to
have HIV antibodies. Of these, 128 of 652 019 (0.02%)
tests were based on ELISA, while in four reports, 14 of
1 350 205 (0.001%) tests were confirmed with supplemental
testing.14,18,25,40 There was no HIV recorded in 18 of the
studies.13,17,19–21,24,27,29–32,34,38,41,42–45 A total of 11 public-sector
blood banks associated with various teaching hospitals yielded
27 reports, with a total of 1 875 532 tested donors identifying
125 subjects (0.0067%) with HIV antibodies. In contrast, only
three studies were conducted at two private hospital blood
banks linked to academic institutes.18,40,45 They reported HIV in
two of 89 101 blood donors (0.002%) who were screened. Four
papers described HIV seroconversion in 14 of the 52 625 blood
donors (0.03%) enrolled in four NGOs,24,35,36,41 while one report
was the combined effort of an NGO with a teaching hospital.27
One study did not mention the names of the blood banks that
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Donor sex and HIV
A total of 17 of the 31 studies on blood donors did not did not
report the sex of the participants. Fourteen reports described
285 208 sex-wise donations, including 258 628 male (90.7%)
and 26 580 female (9.3%) donors.18–21,23,27,28,30–32,37,38,42,45
However, except for one study,18 the HIV results were not
delineated with respect to sex.

Donor type and HIV
Donor types were described in 15 reports only. Khanani
et al. (n = 121) reported the results exclusively in 121 paid/
professional donors and found a single (0.8%) HIV-reactive
donation.14 Similarly, Mujeeb and Mehmood described the HIV
risk in 839 family/replacement or exchange-transfusion donors
and the incidence was reported as nil.19 Six reports described
the HIV risk solely in unpaid voluntary donors,20,27,28,30,36,44
and the result was reported as zero in four reports,20,27,30,44 and
0.2% and 0.045% in two other studies.28,36 However, the latter
studies were ELISA based and their results were not confirmed
through supplemental testing. Four papers described the HIV
seroprevalence in combined unpaid voluntary or family/
replacement donors,23,26,33,37 and the HIV reactivity ranged
from 0.004% to 0.23%. The HIV prevalence in paid and unpaid
donors from slum areas of Karachi was reported in three
reports,13,17,42 but it was reported as nil.

Trend of HIV in blood donors
The data did not show any rising or declining trend of HIV
over a period of 25 years from 1988 when initial cases of HIV
in blood donations were reported.13,14 A frequency of <0.3%
was maintained through the study period, from various places
of the country, irrespective of the donor type and the category
of blood bank.

HIV seroprevalence in blood donors at
Aga Khan University blood bank
From 1998 to 2012, 306 316 blood donors were enrolled and
tested for HIV at the Aga Khan University blood bank; of these,
95.5% were male and 87% were family/replacement donors.
Table 1 summarizes the overall, donor-type and sex-wise
details for HIV seroprevalence. There were 167 donors who
tested positive for HIV. Results of western blot on a total of 16
samples were as follows: positive (n = 5 or 31%), indeterminate
(n = 6 or 38%) and negative (n = 5 or 31%). Donors with indeterminate results were not followed up. Also, overall, in male
and family/exchange donors, the seroprevalence of HIV was
low, ranging from 0.013% to 0.116%. Seroprevalence was not
computed for female and voluntary donors because of small
denominators.
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Author

Year

City

Total n

121
1988 Karachi
Khanani RM
32 127
1994 Karachi
Kayani N
51 257
Kakepoto GN 1996 Karachi
23 278
2002 Peshawar
Khan Z
103 858
2002 Rawalpindi
Khattak MF
910 706
2002 Lahore
Rahman M
3430
2004 Islamabad
Asif N
5000
2004 Quetta
Sheikh AA
94 177
2007 Rawalpindi
Bhatti FA
41 498
2007 Lahore
Sultan F
6659
2009 Lahore
Manzoor I
60 719
2009 Lahore
Shah SAR
127 828
2012 Peshawar
Attaulah S
523
1988 Karachi
Mujeeb SA
1655
1991 Karachi
Mujeeb SA
666
1993 Karachi
Mujeeb SA
33 402
1993 Peshawar
Raziq F
12 482
1996 Lahore
Iqbal J
839
1996 Karachi
Mujeeb SA
960
2000 Abbotabad
Ahmed F
612
2000 Karachi
Mujeeb SA
553
2002 Rawalpindi
Mumtaz S
6000
Mahmood MA 2004 Multan
41 076
2004 Hayatabad
Zaidi A
18 216
2005 Lahore
Sirhindi GA
27 938
2006 Bahawalpur
Fayyaz M
1426
2006 Liaquetpur
Khan MA
139 163
2007 Rawalpindi
Khan ZT
2000
2010 Karachi
Shaikh ZA
5717
2011 Karachi
Borhany M
3915
2011 Peshawar
Khan A
Overall (I2-squared = 89.7%, P < 0.00001)

Positive
1
1
1
2
8
11
8
11
4
11
3
4
77
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0

Prevalence (95% CI)

Weight %

0.00009 (–0.00003, 0.000205)
0.00008 (0.00002, 0.000130)
0.00001 (0.0000049, 0.000019)
0.00233 (0.0007180, 0.003947)
0.00220 (0.0009013, 0.003499)
0.00004 (0.0000009, 0.000084)
0.00027 (0.0001084, 0.000422)
0.00045 (–0.0000592, 0.000960)
0.00007 (0.0000013, 0.000130)
0.00060 (0.0004679, 0.000737)
0.00 (–0.00, 0.00)
0.00 (0.00, 0.00)
0.00 (0.00, 0.00)
(Excluded)
(Excluded)
(Excluded)
(Excluded)
(Excluded)
(Excluded)
(Excluded)
(Excluded)
(Excluded)
(Excluded)
(Excluded)
(Excluded)
(Excluded)
(Excluded)
(Excluded)
(Excluded)
(Excluded)
(Excluded)
0.00111 (–0.00044, 0.00267x)

0.00
1.23
3.12
0.32
1.60
89.54
0.00
0.00
2.63
0.19
0.02
1.09
0.25
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
100.00

–0.0244 0 0.0244
Figure 1: Prevalence of HIV positivity in blood donors in Pakistan
Forest plot showing prevalence (%) estimates (black solid diamonds) with 95% confidence intervals (bars). Shaded boxes denote the weight
allocated to each study based on sample size. The overall pooled prevalence estimate 0.00111% (95% confidence interval [CI] = –0.00044% to
0.00267) was too low to be plotted on the graph.

HIV in transfusion recipients
Seven studies described the prevalence of HIV in multiply
transfused blood recipients, including those with haemophilia,14,45
and polytransfused13,14,42–44,46 and haemodialysed42,44 patients.
Except for one study,45 HIV results were confirmed through
supplemental testing (western blot or p24 antigen). The pooled
data indicated that only 3632 transfusion recipients were

studied and only four were reactive for HIV, with an overall
prevalence of 0.00325% (95% CI = –0.00135 to 0.00648;
see Fig. 2). However, there are too few data to draw any
meaningful conclusions regarding the prevalence of HIV
in blood recipients. All HIV-reactive patients had received
multiple transfusions; 888 of them had had transfusions with
unscreened blood products,13 and two were reported to have
acquired HIV through blood transfusions.13
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Table 1. HIV seroprevalence in blood donors at Aga Khan University blood bank

Year

Donors, n

Males, n (%)

Family/
replacement
donors, n (%)

1998

15 070

14 317 (95)

11 235 (75)

0.013 (0.011 to 0.015)

0.014 (0.012 to 0.014)

0.018 (0.015 to 0.020)

1999

12 300

11 685 (95)

8 636 (70)

0.024 (0.022 to 0.027)

0.026 (0.023 to 0.026)

0.035 (0.031 to 0.039)

2000

15 194

14 434 (95)

11 700 (77)

0.007 (0.005 to 0.008)

0.007 (0.006 to 0.007)

0.009 (0.007 to 0.010)

2001

14 992

14 242 (95)

11 669 (78)

0.013 (0.012 to 0.015)

0.014 (0.012 to 0.014)

0.017 (0.015 to 0.019)

2002

16 333

15 516 (95)

13 180 (81)

0.012 (0.011 to 0.014)

0.013 (0.011 to 0.013)

0.015 (0.013 to 0.017)

2003

18 384

17 465 (95)

15 402 (84)

0.065 (0.062 to 0.069)

0.069 (0.063 to 0.067)

0.065 (0.061 to 0.069)

2004

21 849

20 757 (95)

19 037 (87)

0.064 (0.061 to 0.067)

0.063 (0.062 to 0.066)

0.074 (0.070 to 0.077)

2005

21 411

19 929 (93)

18 368 (86)

0.051 (0.048 to 0.054)

0.055 (0.050 to 0.053)

0.038 (0.035 to 0.041)

2006

22 924

21 632 (94)

20 616 (90)

0.074 (0.071 to 0.078)

0.074 (0.073 to 0.076)

0.058 (0.055 to 0.061)

2007

24 994

24 082 (96)

23 073 (92)

0.120 (0.116 to 0.124)

0.116 (0.112 to 0.120)

0.104 (0.100 to 0.108)

2008

24 191

23 128 (96)

21 434 (87)

0.037 (0.035 to 0.040)

0.039 (0.036 to 0.038)

0.033 (0.030 to 0.035)

2009

25 427

24 709 (97)

24 115 (95)

0.071 (0.068 to 0.074)

0.073 (0.069 to 0.072)

0.070 (0.067 to 0.074)

2010

25 116

24 335 (97)

23 496 (94)

0.044 (0.041 to 0.046)

0.045 (0.043 to 0.045)

0.047 (0.044 to 0.050)

2011

24 572

23 864 (97)

23 120 (94)

0.094 (0.089 to 0.097)

0.096 (0.092 to 0.095)

0.095 (0.091 to 0.099)

2012

23 559

22 557 (96)

21 615 (92)

0.051 (0.048 to 0.054)

0.049 (0.046 to 0.052)

0.051 (0.048 to 0.054)

% HIV prevalence
(95% CI) in donors

% HIV prevalence
(95% CI) in male
donors

% HIV prevalence in
family/replacement
donors

CI: confidence interval.

Discussion
This study showed that the seroprevalence of HIV in
blood donors in Pakistan is low at 0.0011%. Although
repeatedly transfused patients demonstrated an overall HIV
seroprevalence of 0.003%, the number of patients studied was
too small to draw any conclusion. With a national prevalence
rate of 2–3% for viral hepatitis B and C in blood donors,12 HIV
appears to be lowest among the various transfusion-transmitted
viral infections. This seems to be even lower than HIV
seroprevalence in blood donors reported from neighbouring
countries, which is 0.249 % for India,47 0.004% for the Islamic
Republic of Iran,48 and 0.1% for Nepal.49 Overall, the prevalence
seems low, but the limited number of studies retrieved from the
published literature may mean that the calculated figure does
not represent the true prevalence.
The literature search revealed that reports for HIV prevalence
in blood donors were available from only 11 public-sector, 4
NGO and 2 private blood banks. This indicates that published
reports are not representative of all operational blood banks
in the country. In addition, it cannot be assumed that testing
is done routinely, since HIV kits are periodically missing in
public-sector blood banks.7 Since there is no centralized blood
banking at national level, it is hard to analyse the situation with
confidence. Studies have highlighted the alarming situation
in blood banks, whereby prospective donors may be neither
screened not interviewed regarding high-risk behaviour.4,9
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There is currently no insight into the type of blood donation
and HIV surveillance in private blood banks and the majority
of public blood banks, 20–25% of which are dependent on paid
professional donors. These are potentially injection drug users,
among whom the reported HIV prevalence is about 20%.50
One can assume that the reports of low HIV prevalence are
far from reality. Other issues observed were the variance in
methodology, lack of supplemental testing and small sample
size. The poor HIV surveillance and lack of record keeping
in banks would not allow for tracking of blood donors. This
would result in the same HIV-positive subject donating blood
at several places. Individuals reported as replacement donors
might include paid donors as well.25
In 2000, Luby et al. surveyed 37 randomly selected facilities
from a total of 87 in Karachi.4 Only 24 agreed to participate.
Twelve (50%) of the facilities reported regularly utilizing paid
blood donors, while only six (25%) actively recruited volunteer
donors. Only 8% of the surveyed facilities ask donors about
intravascular drug abuse, and none was prepared to ask about
high-risk sexual behaviour. Only 55% were screening for HIV.
It is worth noting that HIV is a taboo subject in the social and
religious culture of the country and therefore direct questioning
related to HIV is often avoided in the blood banks.
In 2005, 63 blood bank services were visited by field workers
under supervision of NACP. A report was prepared by thirdparty evaluation of the quality of HIV screening of blood
products.2 The report warned that 40% of observed blood banks
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Total n

Author

Year

City

Mujeeb SA

1988

Karachi

888 (Polytransfusion)

Mujeeb SA

1993

Karachi

Raziq F

1993

Khanani RM

Positive

Prevalence (95% CI)

Weight

2

0.00225 (–0.00087, 0.00537)

97.09

103 (Polytransfusion)

1

0.00971 (–0.00923, 0.02865)

2.63

Peshawar

33 (Polytransfusion)

1

0.03030 (–0.02818, 0.08879)

0.28

1988

Karachi

25 (Polytransfusion)

0

(Excluded)

0.00

Khanani RM

1988

Karachi

14 (Haemophilia)

0

(Excluded)

0.00

Mujeeb SA

1993

Karachi

168 (Haemodialysis)

0

(Excluded)

0.00

Iqbal J

1996

Lahore

1162 (Polytransfusion)

0

(Excluded)

0.00

Iqbal J

1996

Lahore

987 (Haemodialysis)

0

(Excluded)

0.00

Borhany M

2011

Karachi

173 (Haemophilia)

0

(Excluded)

0.00

Riaz H

2011

Karachi

0

(Excluded)

0.00

79 (Polytransfusion)

Overall I2 = 0.0%, P < 0.485)

0.00325 (–0.00135,0.00648)

–0.0888

0

100.00

0.0888

Figure 2: Prevalence of HIV positivity in blood recipients in Pakistan
Forest plot showing prevalence (%) estimates (black solid diamonds) with 95% confidence intervals (bars). Shaded boxes denote the weight
allocated to each study based on sample size. The pooled prevalence estimate is represented by the open diamond.

had non-availability of HIV kits for periods of 1–12 months.
The same report documented the pooling of blood samples
for HIV screening in four blood banks. The methodology was
predominantly rapid qualitative assay, adopted by 44/63 or
70% of blood banks, while ELISA was utilized in 15/63 or
24% of blood banks. Four banks were not screening for HIV
at all. It was also noted with concern that only two of the 63
surveyed blood banks had a standard operating procedure for
HIV testing, while only one addressed the appropriate storage
of the kits.
A recent survey report by Kassi et al. showed that 4 (17%)
of 23 blood banks were affiliated with either a government
or semi-government institution;9 16 (70%) blood banks had a
healthy donor recruitment programme and 2 (9%) of the blood
banks agreed that they recruited remunerated (paid) blood
donors. Donors were screened for HIV in all 23 blood banks.
The authors’ institutional blood bank data are comparable to
published data from the country. However, the relatively greater
seropositivity in voluntary donors and in females may be a
consequence of the relatively small population denominator
in these cohorts. The trend of HIV seropositivity seemed to
be static over a period of years and the overall frequency still
appears to be low.

Current situation
Owing to the current geopolitical situation, political turmoil
and receding economy, Pakistan spends only 2% of its budget
on health. Communicable diseases like hepatitis, malaria and
tuberculosis are the top priorities for budget allocation. There
is not only a lack of health insurance or medical coverage,
but even hospital stays and medications are self-financed.
Voluntary blood donations are sparse, and centralized blood
banking is non-existent; hospitals are dependent on patients’
attendance for their blood supply. Several items of blood-safety
legislation were approved during 1997 to 2004 and a national
blood policy and strategic framework was laid down in 2008–
2014. However, these were never fully implemented. More
recently, with the initiatives taken by NBTP in the country,
there is hope that the blood-safety system will be reformed.

Strengths and limitations of this study
The study provides a comprehensive review of HIV
seroprevalence in Pakistani blood donors in the past 25
years. It gives an insight into a very low risk of transfusiontransmitted HIV in the country at present. However, the studies
are not representative and reflect only a small proportion of
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the blood that is used clinically in Pakistan. Moreover, nothing
is known about the blood banks that are dependent on paid/
professional donors for their blood supply. Since females are
underrepresented in blood donation, their HIV seroprevalence
remains unknown. Similarly, there is no sustainability in the
performance of public-sector blood banks, as the HIV kits
may periodically be missing. The review was limited by the
variation in the type of studies, patchy information, and lack
of standardization in the methodologies. The number of blood
recipients studied was too small to draw any conclusive result.

With cooperation of the Government of Germany, regional
blood centres are being established, while blood banks that
already exist are reformed.2 Regional blood centres will be
centrally monitored, with strict overall quality management
and HIV surveillance. There is an urgent need to utilize the
existing national HIV surveillance data to prevent the spread
of HIV.51 HIV-reactive donors should be notified to a central
authority and the tracking system should disallow subsequent
donation. Motivation of non-remunerated blood donors is a
key concept that underlies safe blood transfusion,52 and is one
of the initiatives launched by WHO in 2004. The guidelines for
blood transfusions developed by NBTP need to be implemented
to avoid unnecessary transfusions.53 This would use evidencebased practice to drive the transfusion practices of Pakistan’s
physicians/surgeons.54 Serious gaps in knowledge about HIV
have been identified in young people,55–57 including medical
students.58 Nonetheless, media can be used as an effective
tool for mass education about HIV/AIDS,59 and the medical
personnel involved should insist on fully screened blood for
their patients and avoid purchasing blood from unregistered
blood banks.

At present, the published literature indicates a low risk of
HIV transmission through transfusion of blood products in
Pakistan. The data are minimal and patchy, with wide variation
in methodologies that lack standardization. The low prevalence
detected could also be highly significantly confounded by
social and cultural factors. Thus, there is an urgent need
for a national HIV surveillance system of blood donors and
recipients, to elucidate the true magnitude of the HIV burden.
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